Robert might be close with this? Would mean it is the same stock turning over which doesn't add up if there was a accumulator?
SSH smells funny and I don't believe it is deal but it sure was doing a good impression of not breathing. I can't understand managements silence
http://seekingalpha.com/article/402...lles-heel-exposed-attack-part-1?source=nasdaq
In this Part 1, I discuss the following headings -
- The lack of timely disclosure of the first-in-man test of the neuromodulation therapy was unfortunate
- The purchase of the cash consuming Aquadex business and successive Preference Stock offers are not solving ongoing liquidity issues - but are contributing to ever greater dilution of the Common Stock shareholders;
- The target for preferred stock holders seeking control of Sunshine Heart has to be the neuromodulation therapy - a huge prize, potentially in the $100 millions to $billions valuation range;
- The Preferred Stock holders have obtained a seeming stranglehold on the assets of the company. But, their Achilles' heel is exposed, and apparently already under attack;
- Joint venture funding would avoid the necessity for further highly dilutive Convertible Preferred Stock offers.
- Summary and conclusions - How and why opposing interests, and rent-seekers, could drive the share price much higher
- Forums
- ASX - By Stock
- SHC
- SSH 750k volume so far
SSH 750k volume so far, page-38
Featured News
Add SHC (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
EQN
EQUINOX RESOURCES LIMITED.
Zac Komur, MD & CEO
Zac Komur
MD & CEO
SPONSORED BY The Market Online